N-Acetyl-β-D-glucosaminidase in acute myocardial infarction

M. Perwaiz Iqbal, Khawar A. Kazmi, Hasan R. Jafri, Naseema Mehboobali

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


The objective of the study was to investigate whether the lysosomal enzyme, N-Acetyl-β-D-glucosaminidase (NAG) activity is increased in plasma of patients with acute myocardial infarction (AMI) and to determine if there is any association between plasma levels of NAG and severity of myocardial infarction (MI). NAG activity in plasma was monitored in 69 patients with AMI and 135 normal healthy subjects using a spectrofluorimetric method. A modified Aldrich ST elevation score was used to gauge the severity of MI in terms of size of the infarct. Plasma NAG levels in AMI patients and normal healthy subjects were found to be 10.92±7.5 U/I and 6.8±2.2 U/I, respectively. These two mean value when compared by Student's t-test were significantly different P = 0.0001. No statistically significant differences in NAG activity were observed in patients in terms of gender, age, location of infarct, time from onset of chest pain to blood sampling in the hospital and size of the infarct.

Original languageEnglish
Pages (from-to)275-278
Number of pages4
JournalExperimental and Molecular Medicine
Issue number4
Publication statusPublished - 31 Aug 2003


  • Acetylglucosaminidase
  • Biological markers
  • Inflammation
  • Lysosomes
  • Myocardial infarction


Dive into the research topics of 'N-Acetyl-β-D-glucosaminidase in acute myocardial infarction'. Together they form a unique fingerprint.

Cite this